{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T21:26:22Z","timestamp":1768685182273,"version":"3.49.0"},"reference-count":34,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T00:00:00Z","timestamp":1400025600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0096948","type":"journal-article","created":{"date-parts":[[2014,5,14]],"date-time":"2014-05-14T16:29:02Z","timestamp":1400084942000},"page":"e96948","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Telmisartan Activates Endothelial Nitric Oxide Synthase via Ser1177 Phosphorylation in Vascular Endothelial Cells"],"prefix":"10.1371","volume":"9","author":[{"given":"Masahiro","family":"Myojo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arihiro","family":"Kiyosue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masao","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Satonaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Akimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryozo","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasunobu","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,5,14]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.amjcard.2006.01.059","article-title":"Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease","volume":"98","author":"CM Ferrario","year":"2006","journal-title":"Am J Cardiol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"22S","DOI":"10.1016\/S0895-7061(01)02275-0","article-title":"Clinical trials of angiotensin receptor blockers in heart failure: what do we know and what will we learn?","volume":"15","author":"B Pitt","year":"2002","journal-title":"Am J Hypertens"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ahj.2004.04.037","article-title":"Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers","volume":"148","author":"SE Kjeldsen","year":"2004","journal-title":"Am Heart J"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/S0140-6736(07)60242-6","article-title":"Renin-angiotensin system and cardiovascular risk","volume":"369","author":"RE Schmieder","year":"2007","journal-title":"Lancet"},{"key":"ref5","first-page":"S14","article-title":"Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy","volume":"8","author":"TD Giles","year":"2007","journal-title":"Rev Cardiovasc Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"6252","DOI":"10.1073\/pnas.90.13.6252","article-title":"Phosphorylation and subcellular translocation of endothelial nitric oxide synthase","volume":"90","author":"T Michel","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.RES.79.5.984","article-title":"Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress","volume":"79","author":"MA Corson","year":"1996","journal-title":"Circ Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/hr.2008.25","article-title":"A new constitutively active mutant of AMP-activated protein kinase inhibits anoxia-induced apoptosis of vascular endothelial cell","volume":"32","author":"D Nagata","year":"2009","journal-title":"Hypertens Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"31000","DOI":"10.1074\/jbc.M300643200","article-title":"AMP-activated protein kinase (AMPK) signaling in endothelial cells is essential for angiogenesis in response to hypoxic stress","volume":"278","author":"D Nagata","year":"2003","journal-title":"J Biol Chem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1161\/01.CIR.0000136025.96811.76","article-title":"AMP-activated protein kinase inhibits angiotensin II-stimulated vascular smooth muscle cell proliferation","volume":"110","author":"D Nagata","year":"2004","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/01.ASN.0000050415.97942.2F","article-title":"Differential contribution of three mitogen-activated protein kinases to PDGF-BB-induced mesangial cell proliferation and gene expression","volume":"14","author":"H Kawano","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1046\/j.1523-1755.1999.00361.x","article-title":"Hypoxia-induced adrenomedullin production in the kidney","volume":"55","author":"D Nagata","year":"1999","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/01.HYP.0000226054.53527.bb","article-title":"Molecular mechanism of the inhibitory effect of aldosterone on endothelial NO synthase activity","volume":"48","author":"D Nagata","year":"2006","journal-title":"Hypertension"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.CIR.0000127955.36250.65","article-title":"Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-gamma activity","volume":"109","author":"M Schupp","year":"2004","journal-title":"Circulation"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1161\/01.HYP.0000123072.34629.57","article-title":"Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity","volume":"43","author":"SC Benson","year":"2004","journal-title":"Hypertension"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/HJH.0b013e3282f56ba5","article-title":"Inhibition of cardiovascular cell proliferation by angiotensin receptor blockers: are all molecules the same?","volume":"26","author":"SC Benson","year":"2008","journal-title":"J Hypertens"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1253\/circj.CJ-13-0741","article-title":"Effects of telmisartan on inflammatory cytokines and coronary plaque component as assessed on integrated backscatter intravascular ultrasound in hypertensive patients","volume":"78","author":"K Yamaguchi","year":"2014","journal-title":"Circ J"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/hr.2009.187","article-title":"The role of AMP-activated protein kinase in the cardiovascular system","volume":"33","author":"D Nagata","year":"2010","journal-title":"Hypertens Res"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.RES.0000138303.76488.fe","article-title":"Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway","volume":"95","author":"A Tsang","year":"2004","journal-title":"Circ Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"H954","DOI":"10.1152\/ajpheart.00756.2004","article-title":"Functional proteomic analysis of a three-tier PKCepsilon-Akt-eNOS signaling module in cardiac protection","volume":"288","author":"J Zhang","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.cardiores.2006.06.027","article-title":"Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB\/Akt reperfusion injury salvage kinase pathway","volume":"72","author":"M Zhu","year":"2006","journal-title":"Cardiovasc Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1161\/01.CIR.0000012529.00367.0F","article-title":"Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia-reperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation","volume":"105","author":"F Gao","year":"2002","journal-title":"Circulation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.cardiores.2004.10.018","article-title":"Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury","volume":"65","author":"Y Birnbaum","year":"2005","journal-title":"Cardiovasc Res"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/01.fjc.0000137162.14735.30","article-title":"Simvastatin acutely reduces myocardial reperfusion injury in vivo by activating the phosphatidylinositide 3-kinase\/Akt pathway","volume":"44","author":"S Wolfrum","year":"2004","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1161\/01.RES.0000170229.49776.81","article-title":"HMG-CoA reductase inhibitors inhibit endothelial exocytosis and decrease myocardial infarct size","volume":"96","author":"M Yamakuchi","year":"2005","journal-title":"Circ Res"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0735-1097(02)02816-4","article-title":"Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway","volume":"41","author":"RM Bell","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0022-2828(02)00310-3","article-title":"Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS","volume":"35","author":"RM Bell","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s00395-006-0613-4","article-title":"Cardioprotection mediated by rosiglitazone, a peroxisome proliferator-activated receptor gamma ligand, in relation to nitric oxide","volume":"102","author":"AT Gonon","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1161\/HYPERTENSIONAHA.109.143958","article-title":"Telmisartan prevents weight gain and obesity through activation of peroxisome proliferator-activated receptor-delta-dependent pathways","volume":"55","author":"H He","year":"2010","journal-title":"Hypertension"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"H2627","DOI":"10.1152\/ajpheart.91444.2007","article-title":"p38 MAPK-dependent eNOS upregulation is critical for 17beta-estradiol-mediated cardioprotection following trauma-hemorrhage","volume":"294","author":"WH Kan","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"46637","DOI":"10.1074\/jbc.M405547200","article-title":"Activation of endothelial nitric-oxide synthase by the p38 MAPK in response to black tea polyphenols","volume":"279","author":"E Anter","year":"2004","journal-title":"J Biol Chem"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1476-5381.2008.00024.x","article-title":"Levosimendan induces NO production through p38 MAPK, ERK and Akt in porcine coronary endothelial cells: role for mitochondrial K(ATP) channel","volume":"156","author":"E Grossini","year":"2009","journal-title":"Br J Pharmacol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/BF02342228","article-title":"Relation between effects of a set of anti-allergic drugs on calcium pathways and membrane structure in Fc epsilon RI activated signal transduction","volume":"45","author":"MJ Fischer","year":"1996","journal-title":"Inflamm Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1089\/15230860260196218","article-title":"Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: advanced findings from ASK1 knockout mice","volume":"4","author":"A Matsuzawa","year":"2002","journal-title":"Antioxid Redox Signal"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0096948","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T20:45:32Z","timestamp":1540327532000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0096948"}},"subtitle":[],"editor":[{"given":"Ryuichi","family":"Morishita","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,5,14]]},"references-count":34,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,5,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0096948","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,14]]}}}